Evidence that intermittent structured treatment interruption, but not immunization with ALVAC-HIV vCP1452, promotes host control of HIV replication: the results of AIDS Clinical Trials Group 5068 (Q80082535)
Jump to navigation
Jump to search
scientific article published on 01 August 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Evidence that intermittent structured treatment interruption, but not immunization with ALVAC-HIV vCP1452, promotes host control of HIV replication: the results of AIDS Clinical Trials Group 5068 |
scientific article published on 01 August 2006 |
Statements
Evidence that intermittent structured treatment interruption, but not immunization with ALVAC-HIV vCP1452, promotes host control of HIV replication: the results of AIDS Clinical Trials Group 5068 (English)
Joseph J Eron
Michael S Saag
Robert W Coombs
Jeffrey M Jacobson
R Pat Bucy
John Spritzler
Rui Wang
Lawrence Fox
Victoria A Johnson
Susan E Cohn
Donna Mildvan
Dorothy O'Neill
Jennifer Janik
Lynette Purdue
Deborah K O'Connor
Christine Di Vita
Ian Frank
National Institute of Allergy and Infectious Diseases-AIDS Clinical Trials Group 5068 Protocol Team